In a sector note on U.S. Medical Supplies and Devices, UBS initiated coverage of Abbott with a Buy rating and $117 price target.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ABT:
- TD Cowen medical devices analyst to hold analyst/industry conference call
- DexCom pullback on Abbott news a buying opportunity, says Jefferies
- Wells downgrades Edwards Lifesciences with Medtronic gaining share
- BofA says buy DexCom on weakness after Abbott’s Libre gets pump integration
- Tandem pairing with Abbott sensors can be ‘big deal,’ says Lake Street